We had the privilege of presenting our groundbreaking study on the Macustat test at ARVO, where we explored the patient’s perspective on the effectiveness of digital remote monitoring. As pioneers in this field, our focus was to assess patient satisfaction and outcomes using a digital platform for monitoring chronic disease progression in retina patients. Our findings highlighted the significant advantages of integrating digital tools into the management of chronic conditions, particularly for individuals with retinal diseases. 

Find out our poster below